SINGULAR GENOMICS SYSTEMS IN's ticker is OMIC and the CUSIP is 82933R100. A total of 70 filers reported holding SINGULAR GENOMICS SYSTEMS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $382,000 | -39.5% | 100,000 | 0.0% | 0.01% | -23.1% |
| Q1 2022 | $631,000 | -45.4% | 100,000 | 0.0% | 0.01% | -23.5% |
| Q4 2021 | $1,156,000 | +3.3% | 100,000 | 0.0% | 0.02% | 0.0% |
| Q3 2021 | $1,119,000 | -59.3% | 100,000 | 0.0% | 0.02% | -58.5% |
| Q2 2021 | $2,748,000 | – | 100,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Revelation Capital Management, LLC | 2,219,951 | $14,008,000 | 51.22% |
| ARCH Venture Management, LLC | 3,798,926 | $23,971,000 | 3.43% |
| Tikvah Management LLC | 707,600 | $4,465,000 | 1.43% |
| Triatomic Management LP | 221,708 | $1,399,000 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,612,019 | $41,722,000 | 0.93% |
| Perceptive Advisors | 3,655,207 | $23,064,000 | 0.46% |
| Casdin Capital, LLC | 1,442,870 | $9,105,000 | 0.41% |
| Orbimed Advisors | 2,300,792 | $14,518,000 | 0.24% |
| Nicholas Investment Partners, LP | 519,885 | $3,280,000 | 0.23% |
| Alphabet Inc. | 586,584 | $3,701,000 | 0.12% |